Literature DB >> 10896633

Gabapentin therapy for diabetic neuropathic pain.

H E Pérez, G F Sánchez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896633     DOI: 10.1016/s0002-9343(00)00398-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

Review 1.  Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review.

Authors:  Sebastian Straube; Sheena Derry; Henry J McQuay; R Andrew Moore
Journal:  Br J Clin Pharmacol       Date:  2008-04-11       Impact factor: 4.335

Review 2.  Gabapentin for chronic neuropathic pain in adults.

Authors:  Philip J Wiffen; Sheena Derry; Rae F Bell; Andrew Sc Rice; Thomas Rudolf Tölle; Tudor Phillips; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-06-09

Review 3.  WITHDRAWN: Gabapentin for acute and chronic pain.

Authors:  Philip J Wiffen; Henry J McQuay; Jayne Edwards; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

Review 4.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

Review 5.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

Review 6.  Measurement of somatic neuropathy for clinical practice and clinical trials.

Authors:  L V Scott; S Tesfaye
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.